Prognostic significance of autoimmunity during treatment of melanoma with interferon. [electronic resource]
Producer: 20060221Description: 709-18 p. digitalISSN:- 1533-4406
- Adjuvants, Immunologic -- therapeutic use
- Adult
- Aged
- Analysis of Variance
- Autoantibodies -- blood
- Autoimmunity
- Chemotherapy, Adjuvant
- Female
- Follow-Up Studies
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Melanoma -- drug therapy
- Middle Aged
- Neoplasm Staging
- Prognosis
- Proportional Hazards Models
- Recombinant Proteins
- Recurrence
- Skin Neoplasms -- drug therapy
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.